Prostate cancer care | Building on change; lessons learned during the pandemic

Join Ipsen and MIMS Learning for a short series of webinars focusing on the lessons learned during the COVID-19 pandemic and how these can be used to improve prostate cancer care in the future.

This promotional webinar series has been commissioned by Ipsen and is intended for UK healthcare professionals. Products and brands may be mentioned.

Impact of COVID-19 on urology services and prostate cancer care: where do we go from here?

Online | 28 October 2021 @ 7pm

Practical approaches to medicine use for prostate cancer management in primary care during the pandemic

Online | Coming soon

Register for your free place

Click to view prescribing information for Decapeptyl® SR (triptorelin) 3mg, Decapeptyl® SR (triptorelin) 11.25mg and Decapeptyl® SR (triptorelin) 22.5mg.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone on 01753 627777.

September 2021: TRI-UK-004704

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Reversal of benefits after novel migraine prophylactics stopped, study shows

Reversal of benefits after novel migraine prophylactics stopped, study shows

Findings from a recent study indicate a return to pre-treatment...

New products - live tracker

New products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products added...

Deleted products - live tracker

Deleted products - live tracker

EXCLUSIVE TO SUBSCRIBERS See the latest products removed...